Biopharmaceuticals

The State of Things
11:47 am
Fri November 1, 2013

What We Don’t Know About Medical Treatments

When experimental drugs or treatments need to be tested for the market, they generally go through a series of clinical trials. However, a new study shows that nearly one third of all large clinical trials go completely unpublished. This means that information about certain drugs and treatments are not accessible to the public.

Read more
Business & Economy
4:15 pm
Fri July 26, 2013

Leaders Discuss How To Build NC's Biopharmaceutical Industry

RTP headquarters.
Credit Ildar Sagdejev

GlaxoSmithKline hosted a gathering today in RTP for policy, non-profit and business leaders in the biopharmaceutical industry.

Jack Bailey, a Senior Vice President at GSK, says there are well over 100,000 North Carolinians working in the Life Sciences, 5,000 of them at his company.

“So it’s a very big important industry, it’s created a lot of jobs," Bailey says. "And really what we want to do today is start a discussion on how, at this great change in health care, we can make sure both federal, state and local policy decisions get made that continue to accelerate that innovation that comes out of companies like GSK.”

Read more